60 DEGREES PHARMACEUTICALS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $46.10 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-14
- 60 DEGREES PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was $36.10K.
- 60 DEGREES PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was $0.00.
- 60 DEGREES PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-03-31 was $10.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month |
|---|---|---|---|
| 2025-09-30 | $36.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $36.10K derived: sum of 2 quarters · filed 2026-08-14 | $46.10K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $10.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-15 | ||
| 2024-06-30 | $13.77K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |